Respiratory syncytial virus is the most common cause of respiratory tract infections in children. U.S. scientists have conducted a number of studies and experiments, and on Thursday informed the public that a complete first draft of innovative vaccines against this pathogen.
A PC virus is very dangerous for immature immune system of the child. Scientists continue to study drug to prove its effectiveness and safety. The virus causes a deep lungs and begins with the lower respiratory tract. This leads to the development of pneumonia and respiratory failure.
Scientists say that at the moment there are many tools to prevent a huge number of infections, however, a vaccine against respiratory syncytial virus presents for the first time. This development has great potential and is an example of the development of modern medicine.